Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12618001786280Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial of ropivacaine in rib fracture (2 arms), sponsored by Royal Brisbane and Women's Hospital. Primary endpoints: Verbal pain score, Opioid dose used and 1 more. Planned start Dec 2018; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12618001786280.